| Keyword | CPC | PCC | Volume | Score | Length of keyword |
|---|---|---|---|---|---|
| bendamustine moa | 0.91 | 0.8 | 8016 | 14 | 16 |
| bendamustine | 0.78 | 0.8 | 3774 | 22 | 12 |
| moa | 1.02 | 0.5 | 2801 | 50 | 3 |
| Keyword | CPC | PCC | Volume | Score |
|---|---|---|---|---|
| bendamustine moa | 1.77 | 0.9 | 7133 | 16 |
| bendamustine macmillan | 1.37 | 1 | 3770 | 10 |
| bendamustine manufacturer | 1.83 | 0.4 | 3093 | 88 |
| bendamustine maroc | 1.18 | 0.3 | 6032 | 95 |
| bendamustine monographie | 1.49 | 1 | 902 | 78 |
| bendamustine mode of action | 0.66 | 0.2 | 7263 | 31 |
| bendamustine monograph canada | 1.93 | 0.5 | 5244 | 5 |
| bendamustine mantle cell lymphoma | 1.09 | 0.9 | 9964 | 17 |
| bendamustine macmillan info | 1.84 | 0.1 | 5654 | 19 |
| bendamustine and rituximab macmillan | 2 | 0.6 | 4781 | 28 |
| rituximab bendamustine macmillan | 1.51 | 0.1 | 7811 | 13 |
| r bendamustine macmillan | 1.83 | 0.6 | 8439 | 14 |
| polatuzumab bendamustine rituximab macmillan | 1.86 | 0.1 | 6873 | 74 |
| macmillan bendamustine patient information | 1.78 | 0.5 | 5063 | 85 |
